[Home ] [Archive]   [ فارسی ]  
:: Volume 6, Issue 2 (8-2018) ::
J Neyshabur Univ Med Sci 2018, 6(2): 32-40 Back to browse issues page
Comparing cytotoxicity of parthenolide, melphalan, and procarbazine in colon adenocarcinoma and hepatocellular carcinoma cells
Fatemeh B. Rassouli Dr 1
1- , behnam3260@um.ac.ir
Abstract:   (106 Views)
Introduction: Colon adenocarcinoma and hepatocellular carcinoma are among the most prevalent cancers in Iran. Since chemotherapy resistance is a major obstacle in the treatment of these malignancies, it is necessary to introduce novel and more effective anticancer regimens. The purpose of this study was to compare cytotoxicity of parthenolide, a sesquiterpene lactone, with alkylating agents melphalan and procarbazine.
Materials and Methods: To compare toxic effects of parthenolide, melphalan and procarbazine, human colon adenocarcinoma and hepatocellular carcinoma cell lines were used. The viability of HT29 and HepG2 cells was evaluated by MTT assay 24, 48 and 72 h after treatment, and cells were checked for morphological alterations by the end of each time point.
Results: The IC50 values of parthenolide and melphalan in HT29 cells were determined as 8.5 and 160 mg/mL, respectively, while the highest concentration of procarbazine reduced cell viability by only 5%. In addition, the IC50 values of parthenolide and melphalan in HepG2 cells calculated as 15 and 80 mg/mL, respectively, while 160 mg/mL procarbazine reduced cell viability by 11%. To note, morphological changes confirmed MTT results in both cell lines.
Conclusion: Findings of the current study indicated that parthenolide induced more cytotoxic effects in comparison with alkylating drugs. Since this terpenoid derivative effectively reduced the viability of HT29 and HepG2 cells, it could be considered as a potent agent to design new chemotherapy regimens against colon and liver cancers.
Keywords: Colon adenocarcinoma, Hepatocellular carcinoma, Parthenolide, Melphalan, Procarbazine, Cytotoxicity
Full-Text [PDF 1087 kb]   (27 Downloads)    
Type of Study: Orginal Article | Subject: Molecular medicine
Received: 2018/05/28 | Accepted: 2018/09/27 | Published: 2018/11/3
Add your comments about this article
Your username or Email:

CAPTCHA code


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

B. Rassouli F. Comparing cytotoxicity of parthenolide, melphalan, and procarbazine in colon adenocarcinoma and hepatocellular carcinoma cells. J Neyshabur Univ Med Sci. 2018; 6 (2) :32-40
URL: http://journal.nums.ac.ir/article-1-526-en.html


Volume 6, Issue 2 (8-2018) Back to browse issues page
مجله علوم پزشکی نیشابور J Neyshabur Univ Med Sci

*** هرگونه کپی برداری از این سایت بدون ذکر منبع غیر قانونی و همراه با پیگیری های قضایی می باشد *** مجله دانشکده علوم پزشکی نیشابور *** Any copying of this site without citing the source is illegal And is associated with the pursuit of justice ***

Persian site map - English site map - Created in 0.22 seconds with 30 queries by YEKTAWEB 3781